- Home
- KMPR vs PTCT Comparison
KMPR vs PTCT Comparison
Compare KMPR & PTCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KMPR
- PTCT
- Stock Information
- Founded
- KMPR 1990
- PTCT 1998
- Country
- KMPR United States
- PTCT United States
- Employees
- KMPR N/A
- PTCT N/A
- Industry
- KMPR Property-Casualty Insurers
- PTCT Biotechnology: Pharmaceutical Preparations
- Sector
- KMPR Finance
- PTCT Health Care
- Exchange
- KMPR Nasdaq
- PTCT Nasdaq
- Market Cap
- KMPR 3.4B
- PTCT 4.1B
- IPO Year
- KMPR N/A
- PTCT 2013
- Fundamental
- Price
- KMPR $53.40
- PTCT $61.09
- Analyst Decision
- KMPR Buy
- PTCT Buy
- Analyst Count
- KMPR 4
- PTCT 14
- Target Price
- KMPR $67.50
- PTCT $67.00
- AVG Volume (30 Days)
- KMPR 764.9K
- PTCT 1.4M
- Earning Date
- KMPR 10-29-2025
- PTCT 11-06-2025
- Dividend Yield
- KMPR 2.40%
- PTCT N/A
- EPS Growth
- KMPR 562.92
- PTCT N/A
- EPS
- KMPR 5.31
- PTCT 7.72
- Revenue
- KMPR $4,784,500,000.00
- PTCT $1,764,929,000.00
- Revenue This Year
- KMPR $0.77
- PTCT $119.89
- Revenue Next Year
- KMPR $6.74
- PTCT N/A
- P/E Ratio
- KMPR $10.06
- PTCT $7.91
- Revenue Growth
- KMPR 2.67
- PTCT 96.00
- 52 Week Low
- KMPR $45.02
- PTCT $31.80
- 52 Week High
- KMPR $73.01
- PTCT $62.18
- Technical
- Relative Strength Index (RSI)
- KMPR 43.81
- PTCT 75.37
- Support Level
- KMPR $52.84
- PTCT $57.47
- Resistance Level
- KMPR $54.59
- PTCT $58.73
- Average True Range (ATR)
- KMPR 0.91
- PTCT 2.04
- MACD
- KMPR 0.25
- PTCT 0.96
- Stochastic Oscillator
- KMPR 38.31
- PTCT 92.16
About KMPR Kemper Corporation
Kemper Corp is a diversified insurance company that provides services in property and casualty insurance, along with life and health insurance. The company's property and casualty segment offers personal and commercial lines for home and automotive products. The company conducts its operations through two operating segments: Specialty Property & Casualty Insurance, and Life Insurance.
About PTCT PTC Therapeutics Inc.
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.